Pharmarise Holdings Corporation
Symbol: 2796.T
JPX
659
JPYMarknadspris idag
24.8104
P/E-tal
-0.9523
PEG-kvot
7.41B
MRK Aktiekapital
- 0.02%
DIV Avkastning
{{företagets_namn}} (2796-T) Finansiella rapporter
Balansräkning
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 4742 | 3991 | 4604 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -1926 | -2079 | -2427 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 605 | 479 | 926 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 2290 | 2302 | 2587 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 317 | 315 | 260 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 11372 | 10878 | 10546 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 6007 | 6355 | 6432 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 2748 | 3220 | 4025 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 501 | 408 | 438 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3249 | 3628 | 4463 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 2008 | 2139 | 2488 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 778 | 741 | 786 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 4 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 12042 | 12863 | 14173 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 7 | 5 | 5 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 23421 | 23746 | 24724 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 4252 | 4109 | 4609 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 3677 | 2490 | 2819 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 333 | 429 | 573 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5461 | 7422 | 7878 | ||||||||||||||||
Deferred Revenue Non Current | 0 | -42 | -31 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 747 | 691 | 645 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6600 | 8571 | 9001 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 432 | 551 | 700 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 16435 | 17048 | 18393 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 1298 | 1274 | 1251 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 4014 | 3811 | 3494 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 226 | 203 | 208 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1343 | 1319 | 1268 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 6881 | 6607 | 6221 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 23421 | 23746 | 24724 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 105 | 91 | 110 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 6986 | 6698 | 6331 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 82 | 60 | 61 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 9138 | 9912 | 10697 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | 4396 | 5921 | 6093 |
Kassaflödesanalys
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1049 | 1322 | 1202 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1224 | 1308 | 1344 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 513 | -1465 | -139 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 482 | -1319 | 365 | ||||||||||||||||
cash-flows.row.inventory | 0 | 68 | 286 | 56 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 13 | -500 | -582 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -50 | 68 | 22 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -266 | -452 | -462 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -542 | -466 | -552 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -180 | 2 | -116 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 383 | 12 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19 | -209 | -418 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -703 | -292 | -1076 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | -2419 | -2636 | -2857 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1737 | 2199 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -2 | -36 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | -131 | -131 | -129 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 1478 | -2 | 95 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1072 | -1034 | -728 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2 | 0 | -1 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 743 | -613 | 140 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 4734 | 3991 | 4604 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3991 | 4604 | 4464 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 2520 | 713 | 1945 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -542 | -466 | -552 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 1978 | 247 | 1393 |
Resultaträkning rad
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 52030 | 51608 | 52324 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 43896 | 43491 | 44256 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 8134 | 8117 | 8068 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 32 | -7 | 21 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 6695 | 6596 | 6821 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 50591 | 50087 | 51077 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 1 | 1 | 1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 55 | 65 | 75 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -390 | -200 | -45 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 32 | -7 | 21 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -390 | -200 | -45 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 55 | 65 | 75 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1224 | 1308 | 1344 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 1438 | 1520 | 1246 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 1049 | 1322 | 1202 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 702 | 863 | 782 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 333 | 447 | 426 |
Ofta ställda frågor
Vad är Pharmarise Holdings Corporation (2796.T) totala tillgångar?
Pharmarise Holdings Corporation (2796.T) totala tillgångar är 23421000000.000.
Vad är företagets årliga omsättning?
Den årliga intäkten är N/A.
Vad är företagets vinstmarginal?
Företagets vinstmarginal är 0.156.
Vad är företagets fria kassaflöde?
Fritt kassaflöde är 152.963.
Vad är företagets nettovinstmarginal?
Nettovinstmarginalen är 0.006.
Vad är företagets totala intäkter?
Totala intäkter är 0.026.
Vad är Pharmarise Holdings Corporation (2796.T) nettovinst (nettoinkomst)?
Nettovinst (nettoinkomst) är 333000000.000.
Vad är företagets totala skuldsättning?
Den totala skulden är 9138000000.000.
Vad är rörelsens kostnader?
Rörelsens kostnader är 6695000000.000.
Vad är företagets kassaflöde?
Företagets kassa är 0.000.